You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 124 No. 9, September 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Controversies
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Retinal/ Chorioretinal Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Case for Observational Management of Suspected Small Choroidal Melanoma

Arch Ophthalmol. 2006;124:1342-1344.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In December 1997, the ARCHIVES reported the outcome of the Collaborative Ocular Melanoma Study small tumor observational study documenting factors predictive of growth and treatment in this multicenter clinical trial.1 Accompanying that issue was an editorial that delineated the pros and cons to observation vs early treatment for small choroidal melanoma.2 In that editorial, an argument was made for a randomized clinical trial to definitively address the critical clinical question, "Do I treat now or do I wait?" Now approaching the latter half of a decade from this discussion, we as the ophthalmologists managing patients with suspected small choroidal melanomas are still faced with the dilemma as to the best treatment approach for these patients.

Recent advances in clinical oncology and in ocular oncology have focused on delivering early, targeted, definitive therapy to primary malignancies. Cutaneous melanoma management has benefited from aggressive screening programs to identify suspicious lesions, to . . . [Full Text of this Article]


AUTHOR INFORMATION
Timothy G. Murray, MD; Lucia Sobrin, MD
Author Affiliations: Ocular Oncology Service, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Fla (Dr Murray); and Massachusetts Eye and Ear Infirmary, Boston (Dr Sobrin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Treating Some Small Melanocytic Choroidal Lesions Without Waiting for Growth
Jerry A. Shields
Arch Ophthalmol. 2006;124(9):1344-1346.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Cytogenetics in Management of Uveal Melanoma
Shields et al.
Arch Ophthalmol 2008;126:416-419.
FULL TEXT  

Measurement of Human Choroidal Melanoma Xenograft Volume in Rats Using High-Frequency Ultrasound
Braun and Vistisen
IOVS 2008;49:16-22.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.